Related Articles by Review for PMID: 31424767

Year	Number of Results
2001	1
2002	2
2003	2
2004	6
2005	7
2006	4
2007	2
2009	2
2011	2
2013	3
2014	6
2015	6
2016	4
2017	5
2019	2
2020	2
2022	1
2023	2
2024	1
2025	1

1

Kumar C, Zito PM. Kumar C, et al. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424767 Free Books & Documents.

2

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G. D'Amato G, et al. Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. doi: 10.2174/187221307782418900. Recent Pat Inflamm Allergy Drug Discov. 2007. PMID: 19075985 Review.

3

Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria.

Poddighe D, Vangelista L. Poddighe D, et al. Cell Immunol. 2020 Dec;358:104215. doi: 10.1016/j.cellimm.2020.104215. Epub 2020 Sep 12. Cell Immunol. 2020. PMID: 33137647 Review.

4

Anti-IgE Treatment for Disorders Other Than Asthma.

Stokes J. Stokes J. Front Med (Lausanne). 2017 Sep 21;4:152. doi: 10.3389/fmed.2017.00152. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28983485 Free PMC article. Review.

5

Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Kaplan AP, Giménez-Arnau AM, Saini SS. Kaplan AP, et al. Allergy. 2017 Apr;72(4):519-533. doi: 10.1111/all.13083. Epub 2017 Jan 4. Allergy. 2017. PMID: 27861988 Free PMC article. Review.

6

The discovery and development of omalizumab for the treatment of asthma.

Licari A, Marseglia G, Castagnoli R, Marseglia A, Ciprandi G. Licari A, et al. Expert Opin Drug Discov. 2015;10(9):1033-42. doi: 10.1517/17460441.2015.1048220. Epub 2015 May 15. Expert Opin Drug Discov. 2015. PMID: 25979110 Review.

7

Experiences with monoclonal antibody therapy for allergic asthma.

Boushey HA Jr. Boushey HA Jr. J Allergy Clin Immunol. 2001 Aug;108(2 Suppl):S77-83. doi: 10.1067/mai.2001.116434. J Allergy Clin Immunol. 2001. PMID: 11498677 Review.

8

Omalizumab may not inhibit mast cell and basophil activation in vitro.

Gericke J, Ohanyan T, Church MK, Maurer M, Metz M. Gericke J, et al. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1832-6. doi: 10.1111/jdv.12693. Epub 2014 Sep 26. J Eur Acad Dermatol Venereol. 2015. PMID: 25257818 Review.

9

Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.

D'Amato G, Liccardi G, Noschese P, Salzillo A, D'Amato M, Cazzola M. D'Amato G, et al. Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):227-9. doi: 10.2174/1568010043343615. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15379589 Review.

10

Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis.

Félix Toledo R, Negro Alvarez JM, Miralles López JC. Félix Toledo R, et al. Allergol Immunopathol (Madr). 2002 Mar-Apr;30(2):94-9. doi: 10.1016/s0301-0546(02)79097-6. Allergol Immunopathol (Madr). 2002. PMID: 11958741 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31424767

57 results

Results by year